-

Best’s Commentary: Economic Shocks From Ukraine Invasion Fallout to Pressure Global Insurance Industry

LONDON--(BUSINESS WIRE)--AM Best believes that Russia’s invasion of Ukraine likely will impact the global insurance industry substantially in the near to midterm, particularly given the significant fallout in the capital markets and potential for widespread cyber attacks.

In its Best’s Commentary, “Significant Implications of Ukraine Invasion on Global Insurance Industry,” AM Best notes that invasion has had an immediate negative impact on the stock markets worldwide; continued volatility remains likely, challenging efforts by the global central banks and the U.S. Federal Reserve to contain inflation. In addition, sanctions against Russia may have severe knock-on effects not just on oil and commodity prices, but also tourism, as well as the economies of some of the world’s less resilient countries. “Further sanctions may impact the ability of international insurers and reinsurers to underwrite Russian risks or make it more difficult for them to service claims on existing policies,” said Anna Sheremeteva, financial analyst, AM Best. “Most affected would be those writing large energy and infrastructure risks, such as London Market insurers, and international reinsurers.”

“Sanctions also will affect the balance sheets of Russian insurers and their relationships with international partners,” said Todor Kitin, financial analyst, AM Best. “The valuation of investments would be affected by a prolonged equity market downturn, any increase in the Russian Central Bank’s policy rate or a widening of credit spreads. On the other side of the balance sheet, higher-than-anticipated inflation would impact claims costs, with potential implications for the adequacy of reserves.”

Additionally, the impact of an escalating global conflict may increase the risk of a systemic cyber attack and cause substantial economic and insured losses. Heightened risk perception could lead to higher prices in an already hardening cyber market.

To access the full copy of this commentary, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=317816.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2022 by AM Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Anna Sheremeteva
Financial Analyst
+44 20 7397 4397
anna.sheremeteva@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Todor Kitin
Financial Analyst
+44 20 7676 6264
todor.kitin@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Ann Modica
Associate Director, Credit Rating Criteria,
Research and Analytics
+1 908 439 2200, ext. 5209
ann.modica@ambest.com

AM Best


Release Versions
Hashtags

Contacts

Anna Sheremeteva
Financial Analyst
+44 20 7397 4397
anna.sheremeteva@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Todor Kitin
Financial Analyst
+44 20 7676 6264
todor.kitin@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Ann Modica
Associate Director, Credit Rating Criteria,
Research and Analytics
+1 908 439 2200, ext. 5209
ann.modica@ambest.com

Social Media Profiles
More News From AM Best

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...

AM Best Downgrades Credit Ratings of A-CAP Group Members; Maintains Under Review With Negative Implications Status

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating (FSR) to C+ (Marginal) from B (Fair) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “b-” (Marginal) from “bb+” (Fair) of Atlantic Coast Life Insurance Company (Charleston, SC) and Sentinel Security Life Insurance Company (Salt Lake City, UT). Both companies are collectively referred to as A-CAP Group. Concurrently, AM Best has maintained the under review with negative implications status for these Cre...

AM Best to Deliver Presentation at 2026 ACLI Annual Conference

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will speak at the American Council of Life Insurers (ACLI) Annual Conference, which will take place Oct. 14-16, 2026, in Orlando, FL. Kenneth Frino, managing director, and Erik Miller, senior director, both of AM Best, will deliver a presentation, titled, “Life and Annuity Segment in Transition,” during which they will focus on operating results across the life/annuity segment, as well as investment strategies, rating activity trends and AM Best’s segment...
Back to Newsroom